These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9668502)

  • 41. Bovine babesiosis. Seroprevalence and ticks associated with cattle from two different regions of Morocco.
    Sahibi H; Rhalem A; Berrag B; Goff WL
    Ann N Y Acad Sci; 1998 Jun; 849():213-8. PubMed ID: 9668467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Babesia divergens vaccine.
    Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serological responses to Babesia bovis vaccination in cattle previously infected with Babesia bigemina.
    Combrink MP; Troskie PC; Du Plessis F; Latif AA
    Vet Parasitol; 2010 May; 170(1-2):30-6. PubMed ID: 20207488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of Babesia bovis 6cys A and 6cys B as components of transmission blocking vaccines for babesiosis.
    Alzan HF; Bastos RG; Ueti MW; Laughery JM; Rathinasamy VA; Cooke BM; Suarez CE
    Parasit Vectors; 2021 Apr; 14(1):210. PubMed ID: 33879245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a Babesia bovis live attenuated vaccine.
    Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
    Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of different direct diagnostic methods to identify Babesia bovis and Babesia bigemina in animals vaccinated with live attenuated parasites.
    Costa-Júnior LM; Rabelo EM; Martins Filho OA; Ribeiro MF
    Vet Parasitol; 2006 Jun; 139(1-3):231-6. PubMed ID: 16580136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of conventional subunit vaccines for anaplasmosis and babesiosis.
    Montenegro-James S; Johnson WC; Goff WL
    Vet Parasitol; 1995 Mar; 57(1-3):255-66. PubMed ID: 7597788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection.
    Brown WC
    Vet Parasitol; 2001 Nov; 101(3-4):233-48. PubMed ID: 11707299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Babesia bigemina, Babesia argentina, and Anaplasma marginale: Coinfectious immunity in bovines.
    Todorovic RA; Gonzalez EF; Adams LG
    Exp Parasitol; 1975 Apr; 37(2):179-92. PubMed ID: 1123013
    [No Abstract]   [Full Text] [Related]  

  • 52. Residual effect of antibabesial drugs on the live redwater blood vaccines.
    Combrink MP; Troskie PC; De Waal DT
    Ann N Y Acad Sci; 2002 Oct; 969():169-73. PubMed ID: 12381585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serological survey of Babesia bovis, Babesia bigemina, and Anaplasma marginale antibodies in cattle from the semi-arid region of the state of Bahia, Brazil, by enzyme-linked immunosorbent assays.
    Barros SL; Madruga CR; Araújo FR; Menk CF; de Almeida MA; Melo EP; Kessler RH
    Mem Inst Oswaldo Cruz; 2005 Oct; 100(6):513-7. PubMed ID: 16302060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccines against bovine babesiosis--longest field trial?
    Angus BM
    Aust Vet J; 1999 Mar; 77(3):193. PubMed ID: 10197254
    [No Abstract]   [Full Text] [Related]  

  • 55. The impact of 2 dipping systems on endemic stability to bovine babesiosis and anaplasmosis in cattle in 4 communally grazed areas in Limpopo Province, South Africa.
    Rikhotso BO; Stoltsz WH; Bryson NR; Sommerville JE
    J S Afr Vet Assoc; 2005 Dec; 76(4):217-23. PubMed ID: 16642719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigations of breakdowns in protection provided by living Babesia bovis vaccine.
    Bock RE; de Vos AJ; Kingston TG; Shiels IA; Dalgliesh RJ
    Vet Parasitol; 1992 Jun; 43(1-2):45-56. PubMed ID: 1496802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on failure of T strain live Babesia bovis vaccine.
    Bock RE; de Vos AJ; Lew A; Kingston TG; Fraser IR
    Aust Vet J; 1995 Aug; 72(8):296-300. PubMed ID: 8579560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular and antigenic characterisation of ribosomal phosphoprotein P0 from Babesia bovis.
    Ramos CA; Araújo FR; Souza II; Oliveira RH; Elisei C; Soares CO; Sacco AM; Rosinha GM; Alves LC
    Mem Inst Oswaldo Cruz; 2009 Nov; 104(7):998-1002. PubMed ID: 20027467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transplacental transmission of bovine tick-borne pathogens: Frequency, co-infections and fatal neonatal anaplasmosis in a region of enzootic stability in the northeast of Brazil.
    Costa SC; de Magalhães VC; de Oliveira UV; Carvalho FS; de Almeida CP; Machado RZ; Munhoz AD
    Ticks Tick Borne Dis; 2016 Mar; 7(2):270-5. PubMed ID: 26613663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methods currently used for the control of anaplasmosis and babesiosis: their validity and proposals for future control strategies.
    Lawrence JA; de Vos AJ
    Parassitologia; 1990 Apr; 32(1):63-71. PubMed ID: 2284136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.